Novavax COVID-19 vaccine could see approval by May, CEO says

A fourth COVID-19 vaccine could be on the horizon for the U.S., Novavax’s CEO reportedly said Monday.  Stanley Erck said he believes the FDA could potentially grant his company’s vaccine candidate as early as May. Appearing on CNBC’s “Closing Bell,” Erck said

Adhere to Pfizer, Moderna two-dose COVID-19 vaccine regimen, Fauci says: report

National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony Fauci has reiterated that the U.S. will adhere to two-shot coronavirus vaccine regimens for products developed by Pfizer-BioNTech and Moderna, according to a report. Some argue that distributing first doses wider across the population now can cut severe disease

1 2 3 4 5 64